Search results for "Science & Technology"

showing 10 items of 723 documents

A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension

2021

Background Diagnostic delay of chronic thromboembolic pulmonary hypertension (CTEPH) exceeds 1 year, contributing to higher mortality. Health economic consequences of late CTEPH diagnosis are unknown. We aimed to develop a model for quantifying the impact of diagnosing CTEPH earlier on survival, quality-adjusted life-years (QALYs) and healthcare costs. Material and methods A Markov model was developed to estimate lifelong outcomes, depending on the degree of delay. Data on survival and quality of life were obtained from published literature. Hospital costs were assessed from patient records (n=498) at the Amsterdam UMC – VUmc, which is a Dutch CTEPH referral center. Medication costs were ba…

Pulmonary and Respiratory Medicine7medicine.medical_specialtyRespiratory SystemImproved survival610 Medicine & healthQuality of lifeQUALITY-OF-LIFEOriginal Research ArticlesHealth caremedicineEconomic impact analysisIntensive care medicineANGIOPLASTYEconomic consequencesDisease burdenPulmonary Vascular DiseaseScience & Technologybusiness.industry10031 Clinic for AngiologyR2740 Pulmonary and Respiratory MedicineReferral centerMedicineChronic thromboembolic pulmonary hypertensionbusinessLife Sciences & Biomedicine
researchProduct

The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN

2022

Primary ciliary dyskinesia; Rare genetic disorder; Lung diseases Discinesia ciliar primaria; Trastorno genético raro; Enfermedades pulmonares Discinesia ciliar primària; Trastorn genètic rar; Malalties pulmonars Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterised by impaired mucociliary clearance leading to irreversible lung damage. In contrast to other rare lung diseases like cystic fibrosis (CF), there are only few clinical trials and limited evidence-based treatments. Management is mainly based on expert opinions and treatment is challenging due to a wide range of clinical manifestations and disease severity. To improve clinical and translational research and facili…

Pulmonary and Respiratory Medicine:enfermedades respiratorias::trastornos de la motilidad ciliar [ENFERMEDADES]:Health Occupations::Medicine::Pediatrics [DISCIPLINES AND OCCUPATIONS]Respiratory SystemSağlık BilimleriClinical Medicine (MED)SOLUNUM SİSTEMİRespiratory CareHealth SciencesMANAGEMENTKlinik Tıp (MED)Chest Diseases and Allergy:profesiones sanitarias::medicina::pediatría [DISCIPLINAS Y OCUPACIONES]:Otros calificadores::/terapia [Otros calificadores]:Respiratory Tract Diseases::Ciliary Motility Disorders [DISEASES]Internal Medicine SciencesScience & TechnologyKlinik TıpMUTATIONSRESPIRATORY SYSTEM:Other subheadings::/therapy [Other subheadings]Dahili Tıp BilimleriGöğüs Hastalıkları ve AllerjiCLINICAL MEDICINECèl·lules - Motilitat:Congenital Hereditary and Neonatal Diseases and Abnormalities::Genetic Diseases Inborn [DISEASES]TıpPulmons - Malalties - TractamentAkciğer ve Solunum TıbbıMedicineMalalties congènites:enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas [ENFERMEDADES]Solunum BakımıLife Sciences & BiomedicinePulmons Malalties
researchProduct

Continuing professional development: introducing the ERS International Certificate in Respiratory Sleep Medicine

2017

What is the greatest challenge in the delivery of quality care to respiratory disease patients? Is it lack of resources, avoidable harm to patients, or more complex disease presentation? Healthcare delivery has been in the media spotlight in recent months across many countries and the question of how to deliver safe, effective and efficient care to patients remains at the forefront of political agendas at a national level. Education is the passport to the future and the European Respiratory Society (ERS) is in the unique position of being able to work with the most respected respiratory experts internationally in order to design and deliver educational activities to raise standards of train…

Pulmonary and Respiratory Medicinemedicine.medical_specialty5educationRespiratory SystemCertificationSettore MED/10 - Malattie Dell'Apparato RespiratorioSleep medicine/dk/atira/pure/subjectarea/asjc/2700/274003 medical and health sciences0302 clinical medicinemedicine030212 general & internal medicinelcsh:RC705-779Medical educationScience & Technologybusiness.industryEditorialslcsh:Diseases of the respiratory systemCertificatehumanitiesEditorial030228 respiratory systemContinuing professional development18businessLife Sciences & BiomedicineEducation respiratory medicineBreathe
researchProduct

A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample

2011

Lung function measures are heritable traits that predict population morbidity and mortality and are essential for the diagnosis of chronic obstructive pulmonary disease (COPD). Variations in many genes have been reported to affect these traits, but attempts at replication have provided conflicting results. Recently, we undertook a meta-analysis of Genome Wide Association Study (GWAS) results for lung function measures in 20,288 individuals from the general population (the SpiroMeta consortium). OBJECTIVES: To comprehensively analyse previously reported genetic associations with lung function measures, and to investigate whether single nucleotide polymorphisms (SNPs) in these genomic regions…

PulmonologyChronic Obstructive Pulmonary DiseasesEpidemiologyVital Capacitylcsh:MedicineGenome-wide association studyBioinformaticsPDE4DPulmonary function testingPulmonary Disease Chronic Obstructive0302 clinical medicineForced Expiratory VolumePHOSPHODIESTERASE 4D GENElcsh:ScienceLungRISK0303 health scienceseducation.field_of_studyCOPDMultidisciplinaryAlpha 1-antitrypsin deficiencyGreat BritainALPHA(1)-ANTITRYPSIN DEFICIENCYta3141ta3142respiratory system3142 Public health care science environmental and occupational health3. Good healthRespiratory Function Testsmedicine.anatomical_structureGenetic EpidemiologyScience & Technology - Other TopicsMedicineBiological MarkersHEALTHResearch Articlemedicine.medical_specialtyGeneral Science & TechnologyPopulationObstructive pulmonary-disease; Phosphodiesterase 4D gene; Alpha(1)-antitrypsin deficiency; Health; PDE4D; RiskPolymorphism Single NucleotideOBSTRUCTIVE PULMONARY-DISEASE03 medical and health sciencesMeta-Analysis as TopicMolecular geneticsMD MultidisciplinarymedicineGeneticsGenome-Wide Association StudiesHumansGenetic Predisposition to DiseaseeducationBiology030304 developmental biologyAsthmaScience & TechnologyLungMULTIDISCIPLINARY SCIENCESbusiness.industryGenome Humanlcsh:RSmoking Related DisordersSpiroMeta Consortiummedicine.diseaseUnited KingdomAsthmarespiratory tract diseasesGenetics of Diseaselcsh:Qbusiness030217 neurology & neurosurgeryBiomarkersGenome-Wide Association Study
researchProduct

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B…

2016

Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organizatio…

Pulmons -- Malalties obstructivesVeterinary medicineAllergyPublished ErratumLANGUEDOC-ROUSSILLONAllergyRespiratory Medicine and Allergy[SDV]Life Sciences [q-bio]Aparell respiratori -- MalaltiesOPERATIONAL DEFINITIONAlternative medicineReviewChronic respiratory diseasesGLOBAL ALLIANCESYSTEMS MEDICINE0302 clinical medicineMedicine and Health SciencesImmunology and AllergyMACVIA030212 general & internal medicineAIRWAYS ICPLungmedicin och allergiEIP on AHA; European Innovation Partnership on Active and Healthy Ageing; Chronic respiratory diseases; AIRWAYS ICPs; MACVIA; ARIA; Scaling upGINA STRATEGYAIRWAYSUPDATE ARIA 2008Scaling upRespiratory disease:Outras Ciências Agrárias [Ciências Agrárias]3. Good healthChronic respiratory diseaseALLERGIC RHINITISICPsAIRWAYS ICPsGeneral partnershipAction planErratumLife Sciences & BiomedicineAIRWAYS ICPs; ARIA; Chronic respiratory diseases; EIP on AHA; European Innovation Partnership on Active and Healthy Ageing; MACVIA; Scaling upPulmonary and Respiratory Medicinemedicine.medical_specialtyEIP on AHAAIRWAYS ICPs; ARIA; Chronic respiratory diseases; EIP on AHA; European Innovation Partnership on Active and Healthy Ageing; MACVIA; Scaling up; Immunology and AllergyEmerging technologiesImmunologyREFERENCE SITESocio-culturalePredictive medicine03 medical and health sciencesEuropean Innovation Partnership on Active and Healthy AgeingNursingCritical success factorJournal Articlemedicineddc:610Science & TechnologyARIAbusiness.industrySettore MED/09 - MEDICINA INTERNAAIRWAYS-ICPSmedicine.diseaseIntegrated careAlliance030228 respiratory systemCiências Agrárias::Outras Ciências Agrárias3121 General medicine internal medicine and other clinical medicineFamily medicineImmunologyHealthy ageingbusinessSEVERE ASTHMA
researchProduct

The diamond partial order in rings

2013

In this paper we introduce a new partial order on a ring, namely the diamond partial order. This order is an extension of a partial order defined in a matrix setting in [J.K. Baksalary and J. Hauke, A further algebraic version of Cochran's theorem and matrix partial orderings, Linear Algebra and its Applications, 127, 157--169, 1990]. We characterize the diamond partial order on rings and study its relationships with other partial orders known in the literature. We also analyze successors, predecessors and maximal elements under the diamond order.

Pure mathematics15A09Principal ideal010103 numerical & computational mathematicsengineering.material01 natural sciencesCombinatoricsMatrix (mathematics)Linear extensionPrincipal ideal0101 mathematicsCiências Naturais::MatemáticasMathematicsRing (mathematics)RingAlgebra and Number TheoryScience & Technology010102 general mathematicsAnells (Algebra)DiamondOrder (ring theory)Sharp partial orderStar partial orderMinus partial order06A06Linear algebraengineeringÀlgebra linealMATEMATICA APLICADAMaximal element:Matemáticas [Ciências Naturais]
researchProduct

Special elements in a ring related to Drazin inverses

2013

In this paper, the existence of the Drazin (group) inverse of an element a in a ring is analyzed when amk = kan, for some unit k and m; n 2 N. The same problem is studied for the case when a* = kamk-1 and for the fk; s+1g-potent elements. In addition, relationships with other special elements of the ring are also obtained

Pure mathematicsDrazin inverse16E50Inverse010103 numerical & computational mathematicsInvolutory element01 natural sciencesSecondary: 16A300101 mathematicsMathematicsRingRing (mathematics)Science & TechnologyAlgebra and Number TheoryGroup (mathematics)Primary: 15A09010102 general mathematicsAnells (Algebra)15A09 [Primary]PowerDrazin inverseÀlgebra linealElement (category theory)16A30 [Secondary]Unit (ring theory)Linear and Multilinear Algebra
researchProduct

Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells

2017

Three new compounds have been synthesized and completely characterized by analytical and spectroscopic techniques. The new bipyridine-perfluorinated ligand L1 and the new organometallic complex [Ru(η 5 -MeCp)(PPh 3 ) 2 Cl] (Ru1) crystalize in the centrosymmetric triclinic space group P1¯. Analysis of the phenotypic effects induced by both organometallic complexes Ru1 and [Ru(η 5 -MeCp)(PPh 3 )(L1)][CF 3 SO 3 ] (Ru2), on human colorectal cancer cells (SW480 and RKO) survival, showed that Ru2 has a potent anti-proliferative activity, 4–6 times higher than cisplatin, and induce apoptosis in these cells. Data obtained in a noncancerous cell line derived from normal colon epithelial cells (NCM46…

PyridinesApoptosisLigands01 natural sciencesBipyridinechemistry.chemical_compoundDrug DiscoverySelectivityta116Molecular StructureCancro colo-retalChemistryapoptosisCycloparaffinsGeneral Medicine3. Good healthRutheniumsyöpäsolutColorectal NeoplasmsSelectivitymedicine.drugStereochemistryCompostos organometálicoschemistry.chemical_elementAntineoplastic Agentscolorectal cancerTriclinic crystal systemorganometalliyhdisteet010402 general chemistryRutheniumStructure-Activity Relationshipohjelmoitunut solukuolemaCell Line TumorOrganometallic CompoundsmedicineHumansCell ProliferationPharmacologyCisplatinScience & TechnologyDose-Response Relationship DrugApoptose010405 organic chemistryLigandRuthenium methylcyclopentadienylOrganic Chemistryta1182selectivitykompleksiyhdisteetColorectal cancer0104 chemical sciencesperäsuolisyöpäApoptosisCell cultureDrug Screening Assays Antitumorruthenium methylcyclopentadienyl
researchProduct

Measurement of the chi(b) (3 P) mass and of the relative rate of chi(b1) (1 P) and chi(b2) (1 P) production

2014

The production of $\chi_b$ mesons in proton-proton collisions is studied using a data sample collected by the LHCb detector, at centre-of-mass energies of $\sqrt{s}=7$ and $8$ TeV and corresponding to an integrated luminosity of 3.0 fb$^{-1}$. The $\chi_b$ mesons are identified through their decays to $\Upsilon(1S)\gamma$ and $\Upsilon(2S)\gamma$ using photons that converted to $e^+e^-$ pairs in the detector. The $\chi_b(3P)$ meson mass, and the relative prompt production rate of $\chi_{b1}(1P)$ and $\chi_{b2}(1P)$ mesons as a function of the $\Upsilon(1S)$ transverse momentum in the $\chi_b$ rapidity range 2.0< $y$<4.5, are measured. Assuming a mass splitting between the $\chi_{b1}(3P)$ an…

Quantum chromodynamics: Experimental testPhysics::Instrumentation and DetectorsNuclear TheoryQuarkoniumFlavor physics; Hadron-Hadron Scattering; Quarkonium01 natural sciencesPhysics Particles & FieldsHigh Energy Physics - ExperimentLuminositySettore FIS/04 - Fisica Nucleare e Subnucleare14.40.PqFlavor physicsDECAY; UPSILON; PSI[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Flavor physics; Hadron-Hadron Scattering; Quarkonium; Nuclear and High Energy PhysicsPSINuclear ExperimentQCPhysicsPhysicsHadron-induced high- and super-high-energy interactions (energy > 10 GeV): Inclusive production with identified hadronParticle physicsLeptonic semileptonic and radiative decays of J/ψ Υ and other quarkoniaQuarkonium Hadron-Hadron Scattering Flavor physicsPhysical SciencesTransverse momentumFísica nuclearProduction (computer science)LHCParticle Physics - ExperimentNuclear and High Energy PhysicsParticle physicsMesonLHCb - Abteilung HofmannAstrophysics::Cosmology and Extragalactic AstrophysicsUPSILONHadronsNO13.20.Gd0103 physical sciencesRapiditySDG 7 - Affordable and Clean Energy010306 general physicsLarge Hadron Collider (France and Switzerland)/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energyScience & TechnologyHadron-Hadron Scattering010308 nuclear & particles physicsGran Col·lisionador d'HadronsLHCb12.38.QkFlavor physicHigh Energy Physics::ExperimentHeavy quarkonia13.85.NiFísica de partículesExperimentsDECAYProduction rate
researchProduct

A search for new physics in dijet mass and angular distributions in pp collisions at [subscript √s=7] TeV measured with the ATLAS detector

2011

A search for new interactions and resonances produced in LHC proton–proton (pp) collisions at a centre-of-mass energy ps = 7 TeV was performed with the ATLAS detector. Using a dataset with an integrated luminosity of 36 pb−1, dijet mass and angular distributions were measured up to dijet masses of 3.5 TeV and were found to be in good agreement with Standard Model predictions. This analysis sets limits at 95% CL on various models for new physics: an excited quark is excluded for mass between 0.60 and 2.64 TeV, an axigluon hypothesis is excluded for axigluon masses between 0.60 and 2.10 TeV and quantum black holes are excluded in models with six extra space–time dimensions for quantum gravity…

QuarkParticle physicsChiral ColorCiências Naturais::Ciências FísicasPhysics beyond the Standard ModelAstrophysics::High Energy Astrophysical Phenomena:Ciências Físicas [Ciências Naturais]General Physics and AstronomyFOS: Physical sciencesddc:500.2dijet; mass; pp collisionts; ATLAS detector5307. Clean energy01 natural sciencesStandard ModelHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)Atlas (anatomy)Chiral color0103 physical sciencesmedicine[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]String resonance010306 general physicsPhysicsQuantum chromodynamicsLarge Hadron ColliderScience & Technology010308 nuclear & particles physicsParton DistributionsSettore FIS/01 - Fisica SperimentaleHigh Energy Physics::PhenomenologyFísicaHadron CollidersQCDmedicine.anatomical_structureExperimental High Energy Physicsddc:540ComputingMethodologies_DOCUMENTANDTEXTPROCESSINGQuarkFísica nuclearHigh Energy Physics::ExperimentParticle Physics - Experiment
researchProduct